SCHEMBL5016257

SCHEMBL5016257

CCCCOc1ccc([CH]c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.47
▸ CHRNB4 P30926 2/20 0.47
▸ CHRNA3 P32297 2/20 0.47
▸ CHRNA7 P36544 2/20 0.47
▸ CHRNA4 P43681 2/20 0.47
▸ AHR P35869 1/20 0.47
▸ CYP1A1 P04798 2/20 0.46
▸ CYP1B1 Q16678 2/20 0.46
▸ PPARA Q07869 2/20 0.44
▸ FAAH O00519 2/20 0.42
▸ RHOC P08134 1/20 0.40
▸ RHOA P61586 1/20 0.40
▸ LTA4H P09960 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAOB P27338 1/20 0.39
▸ NR5A1 Q13285 1/20 0.39
▸ PTGES O14684 1/20 0.39
▸ ALOX5 P09917 1/20 0.39
▸ PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12409185 0.78 CHRNB2 (0.54) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL26035837 0.77 PSEN1 (0.46) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL5016258 0.77 FAAH (0.48) FAAHRHOCRHOALTA4HMAOB
SCHEMBL2089335 0.77 NR5A1 (0.63) AHRLTA4HNR5A1
SCHEMBL16955554 0.76 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL7440968 0.75 LTA4H (0.63) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL28423723 0.75 NR5A1 (0.56) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL18163146 0.75 ESR1 (0.59) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL6002773 0.75 RHOC (0.48) CYP1A1CYP1B1FAAHRHOCRHOA
SCHEMBL6002774 0.75 FAAH (0.46) PPARAFAAHRHOCRHOALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 — — EP disclosed
Send feedback